Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Malte Peters Insider Profile
4 Followers
Malte Peters, Director at Tango Therapeutics, holds 108.69K shares in Hookipa Pharma (Ticker: HOOK), holds 11.25K shares in Tango Therapeutics (Ticker: TNGX).
Malte Peters has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Malte Peters holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Malte Peters
Malte Peters's Trading History
Tango Therapeutics
Jun 07, 2024
Director
Uninformative Buy
―
$34.88K
Hookipa Pharma
Jul 24, 2024
CEO, Director
Uninformative Buy
―
$219.56K
List of latest transactions for each holding click on a transaction to see Malte Peters's performance on stock
You May Also Like
Malte Peters insider profile FAQ
What is the percentage of profitable transactions made by Malte Peters?
The percentage of profitable transactions made by Malte Peters is ―.
What is the average return per transaction made by Malte Peters?
The average return per transaction made by Malte Peters is ―.
What stocks does Malte Peters hold?
Malte Peters holds: TNGX, HOOK stocks.
What was Malte Peters’s latest transaction?
Malte Peters latest transaction was an Uninformative Buy of ―.
What was Malte Peters's most profitable transaction?
Malte Peters’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Malte Peters's role in Tango Therapeutics?
Malte Peters's role in Tango Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.